Why a leading bird flu expert isn’t convinced that the risk H5N1 poses to people has declined
News that H5N1 avian influenza has breached another mammalian species — this time dairy cows…
Category: Life Sciences
Opinion: Personalized medicine: We’re not there yet
When Francis Collins, then-director of the National Human Genome Research Institute, testified before Congress in…
Opinion: Does addiction make you un-American?
Should Prince Harry be deported from the United States due to his past drug use?…
Baylor wins 2024 STAT Madness with ‘smoke alarm’ for viral disease outbreaks
It began with injecting monkeys with sewage to see if they developed polio. Building off…
STAT+: Nuclear Regulatory Commission advisers beset by conflicts of interest, report finds
The oversight division of a U.S. government agency tasked with ensuring the safe use of…
Dr. Shumard’s Functional Medicine Is Anything but Alternative – USA TODAY
Dr. Shumard’s Functional Medicine Is Anything but Alternative USA TODAY Read Original Article: Dr. Shumard’s Functional…
STAT+: Boehringer Ingelheim layoffs are a sign of dysfunctional Humira biosimilar market
WASHINGTON — Boehringer Ingelheim is laying off or relocating its sales staff for its Humira biosimilar…
Federal judge rules against Philadelphia supervised drug consumption effort
A federal judge this week dealt a major and likely decisive blow to Safehouse, a…
Listen: Biotech mega-rounds, a cancer vaccine setback & CEOs keep their promise
Why is it surprising when drug executives stay true to their word? And can neoantigen…
Why very few people who are eligible for a cochlear implant actually get one
Cochlear implants have successfully improved hearing loss for decades, but few people who qualify for…
Opinion: How climate change is driving a global epidemic of immune health problems, and how to stop it
Many of the effects of climate change play out at a very large scale: Heatwaves…
STAT+: Weed for weight loss, and more from Biotech Land
This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers…
Health tech investor Glen Tullman launches 62 Ventures, a new $100 million fund
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology…
How resurrecting extinct species might impact medicine
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Matt & Adam’s Take: Amylyx did the right thing by withdrawing its ALS drug. That’s rare and worthy of praise
On Thursday morning, Amylyx Pharmaceuticals announced that it would withdraw its ALS drug, Relyvrio, after…
STAT+: Pharmalittle: We’re reading about Amylyx pulling its ALS drug, GLP-1 drugs for Parkinson’s, and more
Top of the morning to you, and a fine one it is. After two days…
STAT+: Amylyx to pull ALS drug from market, cut 70% of staff
Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and…
What ‘de-extinction’ of woolly mammoths can teach us: a Q&A with evolutionary biologist Beth Shapiro
Humans have long tinkered with the evolutionary trajectories of other species. Thousands of years ago…
Opinion: Hospital care costs are out of control. Price caps can help
Here’s just the tip of the iceberg: $722.50 for a nurse to push a drug…
Opinion: For national security, the U.S. must maintain its biotech dominance
For more than a century, the United States has been the undisputed leader in medical…
STAT+: DNA test that predicts opioid addiction should be pulled off the market, critics urge the FDA
In the next 24 hours, more than 130 people will die from opioid-related drug overdoses….
.jpg)
Reedley High School athlete Malachi Rios, with chemo-resistant cancer hopes for miracle in holistic ‘Hope 4 Cancer’ Cancun, Mexico – KGO-TV
Reedley High School athlete Malachi Rios, with chemo-resistant cancer hopes for miracle in holistic ‘Hope…
April 3: Dr. Sharon Harley talks about Integrative Medicine on Drive Time With Dr. Douglass Presented by MDVIP – WCLK
April 3: Dr. Sharon Harley talks about Integrative Medicine on Drive Time With Dr. Douglass…
Over-the-Counter ED Pills and Alternatives to Viagra in 2024 – Healthline
Over-the-Counter ED Pills and Alternatives to Viagra in 2024 Healthline Read Original Article: Over-the-Counter ED Pills…
Covid cut life expectancy by 1.6 years globally, but the leading causes of death haven’t changed since 1990
The leading causes of death haven’t changed since 1990 — with one glaring, pandemic-sized exception. …
Florida accounts for 8% of U.S. abortions. Where will patients go?
Abortion access organizations say they are confronting an imminent crisis with Florida’s forthcoming six-week ban…
Parkinson’s disease may be helped by GLP-1 drug, new study finds
The booming class of GLP-1 drugs that includes Ozempic and Wegovy is not only effective…
STAT+: Mass. senators assail Steward Health Care during hearing on firm’s struggling hospitals
Senators Ed Markey and Elizabeth Warren on Wednesday slammed Steward Health Care and its embattled…
STAT+: Early data from rare-disease trial put spotlight on Moderna’s efforts to turn mRNA into medicines
LONDON — Moderna may be best known for its Covid-19 vaccine, but since its start,…
STAT+: FDA approves TriClip for tricuspid heart valve disease, pitting Abbott against Edwards
The Food and Drug Administration approved a new device from Abbott meant to treat tricuspid…
New data on liquid biopsy for colorectal cancer detection still underwhelms
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a White House drug-shortage plan, a Genmab deal, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Investors funnel $275 million into Paragon Therapeutics spinout
Investors have funneled $275 million into a revamped biotech developing new psoriasis and psoriatic arthritis…
STAT+: As AI proliferates, biopharma companies seek to harness it in clinical trials
For around 20 years, Avi Veidman spent his days in the Israeli intelligence community, analyzing…
Opinion: Medicare coverage of weight loss drugs could save the U.S. billions of dollars
The latest weight loss drugs are good. Really good. They can save lives and could…
What we know about H5N1 bird flu in cows — and the risk to humans
The discovery of H5N1 bird flu in U.S. cattle — and the news that at…
Opinion: I saw the promise of diversity efforts in health care. A moment later I saw its critical gaps
Health care was once moderately immune to the anti-diversity, anti-equity, and anti-inclusion craze. Not anymore….
STAT+: Genmab to buy ProfoundBio for $1.8 billion, the latest deal focused on targeted chemotherapies
LONDON — The Danish firm Genmab said Wednesday it would acquire ProfoundBio for $1.8 billion…
What’s the policy for Sask. doctors around “alternative” therapies? – Regina Leader Post
What’s the policy for Sask. doctors around “alternative” therapies? Regina Leader Post Read Original Article: What’s…
Holistic health options fill Owl River Hall – Lakeland TODAY
Holistic health options fill Owl River Hall Lakeland TODAY Read Original Article: Holistic health options fill…
Medical Advisors Archives – MedShadow Foundation
Medical Advisors Archives MedShadow Foundation Read Original Article: Medical Advisors Archives – MedShadow Foundation »
STAT+: The White House has a plan to stem drug shortages
WASHINGTON — The White House at long last published a plan to stem drug shortages,…
STAT+: Roivant CEO: New deals could ‘materialize later this year’
Can Roivant’s business model survive its success? Roivant Sciences announced two pieces of news Tuesday:…
Lawmakers want to add more Chinese biotechs to defense list
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a European probe into vaccine talks; net drug prices falling, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Gritstone Bio says personalized cancer vaccine falls short in key trial
Gritstone Bio said Monday afternoon that its personalized cancer vaccine didn’t induce more responses than…
STAT+: FDA clears digital stethoscope company’s AI algorithm for heart failure
An AI algorithm to detect heart failure, embedded in a digital stethoscope, earned clearance from…
STAT+: Roivant autoimmune drug succeeds in Phase 2 study in eye condition
A drug being developed by a Roivant subsidiary for a range of autoimmune conditions succeeded…
Verve Therapeutics ‘pauses’ tests of its gene editor for heart disease and prioritizes a backup treatment
Verve Therapeutics said Tuesday that it is pausing testing of its closely watched gene-editing treatment…
STAT+: This AI company scans penis pictures for STIs. Its unproven tech is in an FDA gray zone
Artificial intelligence is already assessing decay in your teeth, abnormalities in your heart rhythm, and…